Haemonetics Corp
NYSE:HAE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Haemonetics Corp
NYSE:HAE
|
US |
|
R
|
Roko AB (publ)
STO:ROKO B
|
SE |
|
T
|
Tamburi Investment Partners SpA
LSE:0G9J
|
IT |
Multiples-Based Value
The Multiples-Based Value of one
HAE
stock under the Base Case scenario is
99.74
USD.
Compared to the current market price of 58.46 USD,
Haemonetics Corp
is
Undervalued by 41%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
HAE Competitors Multiples
Haemonetics Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Haemonetics Corp
NYSE:HAE
|
2.7B USD | 2.1 | 15.6 | 8.8 | 12.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.5T JPY | 10.3 | 37.8 | 27.3 | 32.8 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.4B CHF | 3.5 | 37.6 | 14.5 | 28.2 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
35.6B USD | 0 | 0 | 0 | 0 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
99.8B DKK | 3.5 | 24.4 | 12.9 | 15.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.3B USD | 3 | 29.9 | 12.8 | 17.6 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 1.1 | -16 | 17.1 | 55.4 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
932.1B JPY | 7.2 | 52.9 | 25.1 | 34.1 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
39.2B CNY | 4 | 23 | 34.4 | 34.4 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.3 | 32.5 | 11.4 | 17.8 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37B CNY | 8.1 | 22.2 | 19.9 | 19.9 |